Comparing phenol and laser treatments for pilonidal sinus
Minimally Invasive Treatment of Pilonidal Sinus Disease: Which is Better? Phenol or Laser Ablation
Mersin University · NCT06721169
This study is testing whether phenol or laser treatment works better for adults with pilonidal sinus disease who haven't had treatment before.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 64 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mersin University (other) |
| Locations | 1 site (Mersin) |
| Trial ID | NCT06721169 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of phenol versus laser ablation as minimally invasive treatments for pilonidal sinus disease. It focuses on patients aged 18 and older who have not undergone previous treatment for this condition. The study will collect and analyze clinical characteristics and outcomes to determine which treatment option may provide better results for patients suffering from this common condition. The research addresses a gap in the current understanding of optimal treatment methods for pilonidal sinus disease.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with uncomplicated pilonidal sinus disease who have not received prior treatment.
Not a fit: Patients with complicated pilonidal sinus disease or those who have previously been treated for this condition may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify the most effective minimally invasive treatment for pilonidal sinus disease, improving patient outcomes and quality of life.
How similar studies have performed: While there have been various approaches to treating pilonidal sinus disease, the comparative effectiveness of phenol and laser treatments specifically has not been extensively studied, making this a novel investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 years and older with pilonidal sinus disease * Patients who have not had any previous treatment for pilonidal sinus disease * Patients with uncomplicated pilonidal sinus * Having been diagnosed with pilonidal sinus disease * Patients whose descriptive and clinical characteristics are recorded in their medical files * Those who have signed the Informed Voluntary Consent Form/Written Consent Form Exclusion Criteria: * Patients who have previously been treated for pilonidal sinus disease * Patients with complicated pilonidal sinus disease * Patients aged under 18 * Patients whose descriptive and clinical characteristics are not recorded in their file records * Those who have not signed the Informed Voluntary Consent Form/Written Consent Form
Where this trial is running
Mersin
- Mersin University — Mersin, Turkey (Türkiye) (RECRUITING)
Study contacts
- Study coordinator: Hilmi Bozkurt, Assoc Prof
- Email: hilmibozkurt27@gmail.com
- Phone: +905321780880
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pilonidal Sinus Treatment, Pilonidal Sinus Disorder, Surgical Outcomes, Pilonidal Disease, Phenol, Laser Ablation